Ashley Robert Begnaud, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 548 Lakes Blvd, Breaux Bridge, LA 70517 Phone: 337-332-0661 Fax: 337-332-0651 |
Brittney Alexander Sanders, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1021 School Street, Breaux Bridge, LA 70517 Phone: 337-667-6226 Fax: 337-667-7228 |
Stacey Savoy, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 601 E Bridge St, Breaux Bridge, LA 70517 Phone: 337-332-2857 |
Cheramie Rami, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 225 Champagne Blvd, Breaux Bridge, LA 70517 Phone: 337-442-6506 |
Amanda J Hayes, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 548 Lakes Blvd, Breaux Bridge, LA 70517 Phone: 337-332-0661 |
Dr. Cassie Broussard, FNP-BC, PMHNP-BC DNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1441 Mills Hwy, Breaux Bridge, LA 70517 Phone: 318-405-1031 Fax: 337-324-9049 |
Ms. Christen Keller Linton, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1821 Rees St, Breaux Bridge, LA 70517 Phone: 337-442-6659 |
Patricia Marie Johnson, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1451 E Bridge St, Breaux Bridge, LA 70517 Phone: 337-322-2210 Fax: 337-322-2220 |
Teresa M Margaglio, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1555 Gary Dr Ste C, Breaux Bridge, LA 70517 Phone: 337-332-0222 |
Christi Danielle Carmouche, APRN, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1555 Gary Dr Ste C, Breaux Bridge, LA 70517 Phone: 337-909-2460 |
News Archive
Peregrine Pharmaceuticals, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,611,704, which includes broad claims covering anti-viral uses of phosphatidylserine (PS)-targeting antibodies including Peregrine's lead clinical compound, bavituximab. PS is a unique marker exposed on the surface of virally infected cells that can be targeted to treat a broad spectrum of virus infections.
Senomyx, Inc. announced today the pricing of an underwritten public offering of 7,142,857 shares of its common stock at a price to the public of $2.80 per share. The gross proceeds from the sale of the shares, before underwriting discounts and commissions and other offering expenses, are expected to be approximately $20.0 million. The offering is expected to close on or about February 18, 2010, subject to customary closing conditions. Senomyx has also granted the underwriters a 30-day option to purchase up to an aggregate of 1,071,428 additional shares of common stock to cover over-allotments, if any.
A report by scientists from The Netherlands published online in The FASEB Journal identifies a compound in human saliva that greatly speeds wound healing.
Domainex Ltd, a private drug discovery service company, today announces that it is launching an integrated bioassay service platform, BioassayBuilder.
In Massachusetts, approximately 70% of those with Alzheimer's disease are cared for at home, so the Alzheimer's Association is preparing for a surge in calls to its 24/7 Helpline during the holiday season. For most families, holidays are filled with opportunities for togetherness and sharing, but for a family dealing with Alzheimer's, holidays can also be stressful and filled with special challenges, according to the experts at the Alzheimer's Association.
› Verified 8 days ago